These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 4214985)
1. [Non-specific basic therapy of leukemias and their complications]. Brittinger G Med Klin; 1974 Aug; 69(34):1344-51. PubMed ID: 4214985 [No Abstract] [Full Text] [Related]
2. [Basic therapy in children with leukemia and a malignant tumors. II]. Fuchs D; Hermann J; Zintl F; Plenert W Kinderarztl Prax; 1978 Mar; 46(3):133-45. PubMed ID: 25986 [No Abstract] [Full Text] [Related]
5. Supportive therapy for the leukemic patient in acute relapse. Pochedly C Med Times; 1977 Jul; 105(7):(82)1d-(82)9d. PubMed ID: 875679 [No Abstract] [Full Text] [Related]
6. [Supportive treatment in hemopathies]. Juliá Font A Sangre (Barc); 1984; 29(4-C):668-73. PubMed ID: 6440299 [No Abstract] [Full Text] [Related]
7. [Indications and contraindications for blood transfusions in internal medicine]. Buchborn E; Schulz E; Zach J Internist (Berl); 1969 Feb; 10(2):60-5. PubMed ID: 4903261 [No Abstract] [Full Text] [Related]
8. Advances in the management of acute nonlymphocytic leukemia. Wiernik PH Arch Intern Med; 1976 Dec; 136(12):1399-403. PubMed ID: 826228 [No Abstract] [Full Text] [Related]
9. Proceedings: Treatment of acute leukaemia in adults. Vincent PC; Gunz FW; Levi JA Med J Aust; 1974 Jun; 1(26):1035-8. PubMed ID: 4527946 [No Abstract] [Full Text] [Related]
10. Adenosine metabolism in plasma and platelets. IV. Elevated plasmatic adenosine deaminase activity, impaired platelet 14C-adenosine incorporation and hemostatic dysfunction in chronic myeloid leukemia. Pinkhas J; Chivot JJ; Michel H; Caen J Rev Eur Etud Clin Biol; 1970 Dec; 15(10):1108-13. PubMed ID: 5281044 [No Abstract] [Full Text] [Related]
11. [Conservative therapy of chronic renal failure]. Reubi F Helv Med Acta Suppl; 1969; 49():88-99. PubMed ID: 4192458 [No Abstract] [Full Text] [Related]
12. Allopurinol and the control of hyperuricemia in neoplastic disease. Med Lett Drugs Ther; 1968 Dec; 10(25):103-4. PubMed ID: 5731801 [No Abstract] [Full Text] [Related]
17. [Allopurinol in the prevention and treatment of urate complications in leukemia]. Aldo C; Roberto M Haematologica; 1969; 54(1):17-28. PubMed ID: 4978717 [No Abstract] [Full Text] [Related]
18. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Siu YP; Leung KT; Tong MK; Kwan TH Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385 [TBL] [Abstract][Full Text] [Related]
19. Blood: use and abuse of whole blood and fractions. Saidi P Clin Ther; 1983; 5(4):327-34. PubMed ID: 6871916 [TBL] [Abstract][Full Text] [Related]
20. Use of allopurinol for control of hyperuricemia in leukemia and lymphoma. DeConti RC; Calabresi P Conn Med; 1967 Jun; 30(6):430-6. PubMed ID: 6046076 [No Abstract] [Full Text] [Related] [Next] [New Search]